Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey

Michal Shteinberg; Arietta Spinou; Pieter Goeminne; Megan Crichton; Charles Haworth; James D Chalmers

doi:10.1183/23120541.00724-2023

Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey

Michal Shteinberg (Lead / Corresponding author)
, Arietta Spinou
, Pieter Goeminne
, Megan Crichton
, Charles Haworth
, James D Chalmers

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

176 Downloads (Pure)

Abstract

Specialists caring for people with bronchiectasis recommend specialised nebulisers for inhaled antibiotics, but are often limited by availability and cost of nebulisation devices.

Original language	English
Article number	00724-2023
Number of pages	4
Journal	ERJ Open Research
Volume	10
Issue number	1
Early online date	15 Jan 2024
DOIs	https://doi.org/10.1183/23120541.00724-2023
Publication status	Published - Jan 2024

Access to Document

10.1183/23120541.00724-2023Licence: CC BY-NC

Final published versionFinal published version, 317 KBLicence: CC BY-NC

GREAT-2: A phase 2 trial of Gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection
Chalmers, J. (Investigator)
European Respiratory Society
1/11/22 → 31/10/25
Project: Research

Cite this

@article{256dc586b01a4fe3b232c27cf8d9a2f0,

title = "Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey",

abstract = "Specialists caring for people with bronchiectasis recommend specialised nebulisers for inhaled antibiotics, but are often limited by availability and cost of nebulisation devices.",

author = "Michal Shteinberg and Arietta Spinou and Pieter Goeminne and Megan Crichton and Charles Haworth and Chalmers, \{James D\}",

note = "Copyright {\textcopyright}The authors 2024.",

year = "2024",

month = jan,

doi = "10.1183/23120541.00724-2023",

language = "English",

volume = "10",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "European Respiratory Society",

number = "1",

}

TY - JOUR

T1 - Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis

T2 - results of a specialist survey

AU - Shteinberg, Michal

AU - Spinou, Arietta

AU - Goeminne, Pieter

AU - Crichton, Megan

AU - Haworth, Charles

AU - Chalmers, James D

PY - 2024/1

Y1 - 2024/1

N2 - Specialists caring for people with bronchiectasis recommend specialised nebulisers for inhaled antibiotics, but are often limited by availability and cost of nebulisation devices.

AB - Specialists caring for people with bronchiectasis recommend specialised nebulisers for inhaled antibiotics, but are often limited by availability and cost of nebulisation devices.

U2 - 10.1183/23120541.00724-2023

DO - 10.1183/23120541.00724-2023

M3 - Letter

C2 - 38226061

SN - 2312-0541

VL - 10

JO - ERJ Open Research

JF - ERJ Open Research

IS - 1

M1 - 00724-2023

ER -

Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey

Abstract

Access to Document

Fingerprint

Projects

GREAT-2: A phase 2 trial of Gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection

Cite this